4004 ESC Guidelines label use of medication should be limited to situations where it is in the patient's interest to do so, with regard to the quality, safety, and efficacy of care, and only …
• The specific situation of the patient. Unless otherwise provided for by national regulations, off-label use of medication should be limited to situations where it is in the patient's interest …
A Nogami, T Kurita, H Abe, K Ando, T Ishikawa… - Circulation …, 2021 - jstage.jst.go.jp
Pacemaker treatment for bradyarrhythmia was first approved for national health insurance coverage in Japan in 1974, and its use rapidly became widespread thereafter …
J Knuuti, W Wijns, A Saraste, D Capodanno… - European heart …, 2020 - academic.oup.com
Health professionals are encouraged to take the ESC Guidelines fully into account when exercising their clinical judgment, as well as in the determination and the implementation of …
H Tsutsui, M Isobe, H Ito, K Okumura, M Ono… - Circulation …, 2019 - jstage.jst.go.jp
Heart Failure Society (JHFS). The working committee for this project includes members and collaborators involved in the previous versions of the heart failure guidelines and members …
1–«МНОЦ МГУ им. МВ Ломоносова», 119192, Москва, Ломоносовский пр-кт, д. 27, корп. 10 2–ФГБОУ ВО «ПИМУ» МЗ РФ, 603950, Нижний Новгород, пл. Минина и Пожарского …
K Kimura, T Kimura, M Ishihara, Y Nakagawa… - Circulation …, 2019 - jstage.jst.go.jp
Acute coronary syndromes (ACS) are a comprehensive disease concept characterized by acute myocardial ischemia caused by disruption of coronary artery plaque and consequent …
The recommendations listed in this clinical practice guideline are, whenever possible, evidence-based. An initial extensive evidence review, which included literature derived from …
5.2. 1. Ocena funkcji skurczowej lewej komory...................................... 1052 5.2. 2. Ocena funkcji rozkurczowej lewej komory...................................... 1052 5.2. 3. Ocena funkcji prawej …